0.6247 USD
-0.01 (-0.83%)
0.63 USD
+0.01 (+0.85%)
We assign a fundamental rating of 3 out of 10 to XTNT. XTNT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XTNT have multiple concerns. XTNT is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year XTNT was profitable.
XTNT had a positive operating cash flow in the past year.
In the past 5 years XTNT reported 4 times negative net income.
In the past 5 years XTNT reported 4 times negative operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -4.43%, XTNT is doing good in the industry, outperforming 67.55% of the companies in the same industry.
With a decent Return On Equity value of -9.44%, XTNT is doing good in the industry, outperforming 67.02% of the companies in the same industry.
XTNT's Return On Invested Capital of 0.03% is fine compared to the rest of the industry. XTNT outperforms 64.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.43% | ||
| ROE | -9.44% | ||
| ROIC | 0.03% |
ROA(3y)-10.3%
ROA(5y)-11.34%
ROE(3y)-20.61%
ROE(5y)-25.18%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
XTNT has a Operating Margin of 0.02%. This is in the better half of the industry: XTNT outperforms 64.89% of its industry peers.
XTNT has a Gross Margin of 60.16%. This is comparable to the rest of the industry: XTNT outperforms 58.51% of its industry peers.
In the last couple of years the Gross Margin of XTNT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.02% | ||
| PM (TTM) | N/A | ||
| GM | 60.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-2.41%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so XTNT is destroying value.
The number of shares outstanding for XTNT has been increased compared to 1 year ago.
The number of shares outstanding for XTNT has been increased compared to 5 years ago.
The debt/assets ratio for XTNT is higher compared to a year ago.
2.2 Solvency
XTNT has an Altman-Z score of -0.75. This is a bad value and indicates that XTNT is not financially healthy and even has some risk of bankruptcy.
XTNT has a Altman-Z score (-0.75) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.46 indicates that XTNT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.46, XTNT perfoms like the industry average, outperforming 45.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.75 |
ROIC/WACC0
WACC9.03%
2.3 Liquidity
A Current Ratio of 2.47 indicates that XTNT has no problem at all paying its short term obligations.
XTNT has a Current ratio (2.47) which is in line with its industry peers.
XTNT has a Quick Ratio of 1.16. This is a normal value and indicates that XTNT is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, XTNT is doing worse than 70.74% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
XTNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.69%, which is quite impressive.
XTNT shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.44%.
The Revenue has been growing by 12.64% on average over the past years. This is quite good.
EPS 1Y (TTM)107.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)28.44%
Revenue growth 3Y28.5%
Revenue growth 5Y12.64%
Sales Q2Q%19.04%
3.2 Future
Based on estimates for the next years, XTNT will show a very strong growth in Earnings Per Share. The EPS will grow by 30.30% on average per year.
XTNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.31% yearly.
EPS Next Y108.5%
EPS Next 2Y42.92%
EPS Next 3Y30.31%
EPS Next 5YN/A
Revenue Next Year10.6%
Revenue Next 2Y0.34%
Revenue Next 3Y3.31%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 62.47, which means the current valuation is very expensive for XTNT.
Based on the Price/Earnings ratio, XTNT is valued a bit cheaper than the industry average as 67.55% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.15. XTNT is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 122.49, the valuation of XTNT can be described as expensive.
XTNT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. XTNT is cheaper than 64.36% of the companies in the same industry.
XTNT is valuated expensively when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.47 | ||
| Fwd PE | 122.49 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, XTNT is valued a bit cheaper than the industry average as 72.87% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 25.58 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XTNT's earnings are expected to grow with 30.30% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y42.92%
EPS Next 3Y30.31%
5. Dividend
5.1 Amount
No dividends for XTNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.6247
-0.01 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners57.12%
Inst Owner Change-8.18%
Ins Owners14.93%
Ins Owner Change12.22%
Market Cap87.46M
Revenue(TTM)117.27M
Net Income(TTM)-4.58M
Analysts85
Price Target1.53 (144.92%)
Short Float %0.07%
Short Ratio0.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)198.04%
Min EPS beat(2)100%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)77.12%
Min EPS beat(4)-56.86%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)73.86%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.07%
Min Revenue beat(2)3.39%
Max Revenue beat(2)10.74%
Revenue beat(4)2
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-6.52%
Max Revenue beat(4)10.74%
Revenue beat(8)6
Avg Revenue beat(8)5.84%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.29%
PT rev (3m)-14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.47 | ||
| Fwd PE | 122.49 | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | 58.27 | ||
| P/B | 1.8 | ||
| P/tB | 2.59 | ||
| EV/EBITDA | 25.58 |
EPS(TTM)0.01
EY1.6%
EPS(NY)0.01
Fwd EY0.82%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY1.72%
SpS0.91
BVpS0.35
TBVpS0.24
PEG (NY)0.58
PEG (5Y)N/A
Graham Number0.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.43% | ||
| ROE | -9.44% | ||
| ROCE | 0.04% | ||
| ROIC | 0.03% | ||
| ROICexc | 0.03% | ||
| ROICexgc | 0.04% | ||
| OM | 0.02% | ||
| PM (TTM) | N/A | ||
| GM | 60.16% | ||
| FCFM | N/A |
ROA(3y)-10.3%
ROA(5y)-11.34%
ROE(3y)-20.61%
ROE(5y)-25.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.35%
GM growth 5Y-2.41%
F-Score5
Asset Turnover1.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.97 | ||
| Cap/Depr | 97.07% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 0.01 | ||
| Cash Conversion | 33.42% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | -0.75 |
F-Score5
WACC9.03%
ROIC/WACC0
Cap/Depr(3y)93.26%
Cap/Depr(5y)102.58%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y108.5%
EPS Next 2Y42.92%
EPS Next 3Y30.31%
EPS Next 5YN/A
Revenue 1Y (TTM)28.44%
Revenue growth 3Y28.5%
Revenue growth 5Y12.64%
Sales Q2Q%19.04%
Revenue Next Year10.6%
Revenue Next 2Y0.34%
Revenue Next 3Y3.31%
Revenue Next 5YN/A
EBIT growth 1Y100.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year230.8%
EBIT Next 3Y49%
EBIT Next 5YN/A
FCF growth 1Y74.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.46%
OCF growth 3YN/A
OCF growth 5YN/A
XTANT MEDICAL HOLDINGS INC / XTNT FAQ
What is the fundamental rating for XTNT stock?
ChartMill assigns a fundamental rating of 3 / 10 to XTNT.
What is the valuation status of XTANT MEDICAL HOLDINGS INC (XTNT) stock?
ChartMill assigns a valuation rating of 4 / 10 to XTANT MEDICAL HOLDINGS INC (XTNT). This can be considered as Fairly Valued.
How profitable is XTANT MEDICAL HOLDINGS INC (XTNT) stock?
XTANT MEDICAL HOLDINGS INC (XTNT) has a profitability rating of 3 / 10.
What is the valuation of XTANT MEDICAL HOLDINGS INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for XTANT MEDICAL HOLDINGS INC (XTNT) is 62.47 and the Price/Book (PB) ratio is 1.8.